Market Place
Sourcing Support
Avadel Pharmaceuticals Gets FDA Approval For LUMRYZ™ Suspension
17 Oct 2024 //
GLOBENEWSWIRE
Avadel Pharma Publishes Data On LUMRYZ Efficacy In Narcolepsy
25 Sep 2024 //
GLOBENEWSWIRE
Avadel Publishes RESTORE Data Favoring Once-Nightly LUMRYZ Dosing
03 Sep 2024 //
GLOBENEWSWIRE
Avadel`s LUMRYZ Data On Weight Loss In Narcolepsy Published
20 Aug 2024 //
GLOBENEWSWIRE
Avadel Doses First Patient In Phase 3 LUMRYZ™ Trial For Hypersomnia
31 Jul 2024 //
GLOBENEWSWIRE
Avadel Shares LUMRYZ Data At SLEEP 2024
22 May 2024 //
GLOBENEWSWIRE
Avadel Q1 2024 Update, Financial Results
08 May 2024 //
GLOBENEWSWIRE
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ
20 Oct 2023 //
GLOBENEWSWIRE
Avadel launches quick start to narcolepsy drug’s marketing
10 Jul 2023 //
ENDPTS
Amneal Launches Authorized Generic for Xyrem
03 Jul 2023 //
BUSINESSWIRE
FDA faces lawsuit from Jazz after approval of Avadel`s sleep aid
24 Jun 2023 //
FIERCE PHARMA
Avadel to Host Commercial Day on June 29 for LUMRYZ (sodium oxybate)
22 Jun 2023 //
GLOBENEWSWIRE
D&A Pharma : Despite the latest alarming figures on alcohol dependence
22 Jun 2023 //
PR NEWSWIRE
Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ
05 Jun 2023 //
GLOBENEWSWIRE
FDA endorses Avadel`s Lumryz, a major threat to Jazz`s Xyrem
03 May 2023 //
ENDPTS
Avadel Pharmaceuticals Lumryz (sodium oxybate) Receives Approval in the U.S
01 May 2023 //
FDA
Avadel Announces Final FDA Approval of sodium oxybate
01 May 2023 //
GLOBENEWSWIRE
Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug
24 Feb 2023 //
REUTERS
Hikma Pharma launches Xyrem’s generic in US
04 Jan 2023 //
EXPRESS PHARMA
Hikma introduces generic Xyremin US market
03 Jan 2023 //
PHARMABIZ
In Jazz case, FTC urges court to delist patent on blockbuster Xyrem
15 Nov 2022 //
FIERCEPHARMA
Avadel Presents Positive Clinical Data for FT218
09 Jun 2021 //
GLOBENEWSWIRE
Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™
20 Oct 2020 //
PRNEWSWIRE
Avadel Pharmaceuticals Announces FT218 Leadership Transition
14 Sep 2020 //
GLOBENEWSWIRE
Jazz Pharmaceuticals to Present New Data on Xywav™ Oral Solution
26 Aug 2020 //
PRNEWSWIRE
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav™
22 Jul 2020 //
PRNEWSWIRE
Jazz’s Xyrem follow-up flies through phase 3
27 Sep 2019 //
FIERCE BIOTECH
As investors fret about Xyrem durability, Jazz spends $52M+ upfront
14 Aug 2019 //
ENDPTS
Jazz plans early July launch for sleepiness med Sunosi after DEA scheduling
18 Jun 2019 //
FIERCE PHARMA
Pfizer, ‘never say never’ with big M&A, inks $11.4B Array cancer deal
18 Jun 2019 //
FIERCE PHARMA
Jazz Pharms` Announces FDA Approval of Xyrem® (sodium oxybate) for Cataplexy
29 Oct 2018 //
PR NEWSWIRE
U.S. court denies Jazz Pharma bid to revive patents on narcolepsy drug
13 Jul 2018 //
REUTERS
Jazz Pharma gets FDA nod for Xyrem to Treat Cataplexy and EDS
28 Jun 2018 //
BIOSPECTRUM
Jazz`s Announces FDA Acceptance of sNDA for Xyrem® (sodium oxybate)
27 Jun 2018 //
PR NEWSWIRE
Xyrem®(Sodium Oxybate): Jazz Pharmaceuticals v. Lupin
24 Apr 2018 //
PATENT LITIGATION
Xyrem®( Sodium Oxybate): Jazz Pharmaceuticals V. Mallinckrodt
03 Jan 2018 //
PATENT LITIGATION
Xyrem® (Sodium Oxybate): Jazz Pharmaceuticals V. Ascent Pharmaceuticals, Inc.
27 Jul 2017 //
PATENT LITIGATION
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
06 Jul 2017 //
BLOOMBERG
Xyrem (Sodium Oxybate): Jazz Pharmaceuticals v. Amneal Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Jazz Pharma Reaches Settlement with Hikma Pharma Related Xyrem Patent Litigation
06 Apr 2017 //
PR NEWSWIRE
Jazz Pharma Announces 1st Patient Enrolled in Ph3 Clinical Study JZP-258
15 Mar 2017 //
PR NEWSWIRE
Avadel Pharmaceuticals: A Buy With A $17 Price Target
09 Mar 2017 //
SEEKINGALPHA
Amneal`s Generic Sodium Oxybate Receives Tentative Approval In US
19 Jan 2017 //
FDA
Ohm Labs Inc`s Generic Sodium Oxybate Receives Tentative Approval In US
19 Jan 2017 //
FDA
FDA approves generic version of Jazz Pharma`s sleep disorder drug
19 Jan 2017 //
REUTERS
West-Ward Pharms Int`s Generic Sodium Oxybate Receives Approval In US
17 Jan 2017 //
FDA
Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer
03 Jan 2017 //
GLOBENEWSWIRE
Noted price-hiker Jazz feels the heat as PTO strikes Xyrem patents
03 Aug 2016 //
FIERCE PHARMA
After holiday weekend rumors, Jazz confirms $1.5B buyout of tiny Celator
01 Jun 2016 //
FIERCE BIOTECH
U.S. FDA to allow Amarin to promote fish oil pill for off-label use
08 Mar 2016 //
REUTERS
